AquaBounty Technologies Inc

Aktienanalyse zu AquaBounty Technologies Inc (AQB)

$1.250

-0.057 (-4.58%)Zum Schluss

Loading chart…
High
1.320
Open
1.290
VWAP
1.27
Vol
42.13K
Mkt Cap
6.40M
Low
1.250
Amount
53.65K
EV/EBITDA, TTM
0.00

AquaBounty Technologies, Inc. is a land-based aquaculture company. The Company’s technology advances in fish breeding, genetics, and health and nutrition. It locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.

AI analysis of AquaBounty Technologies Inc (AQB)

sell

AquaBounty Technologies Inc is not a good buy right now due to its current price of 1.25, which is significantly below its 200-day simple moving average of 0.985, indicating a bearish trend. Additionally, the RSI is at 37.249, suggesting the stock is nearing oversold territory but has not yet shown signs of recovery. The company has reported consistent losses, with a net income loss of -16,309,967 in Q2 2026, and a forward P/E ratio of 0, indicating no earnings growth expected in the near term. The main risk is the significant drop in stock price over the last 5 days by -4.58%, which reflects negative market sentiment and volatility.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 1.25
Tief
Durchschnitt
Hoch

HC Wainwright & Co.

2024-05-16

Kursziel

Hold

Oppenheimer

2024-04-02

Kursziel

Hold

HC Wainwright & Co.

2023-11-08

Kursziel

Hold

Oppenheimer

2023-10-20

Kursziel

Hold

Oppenheimer

2023-08-02

Kursziel

$30

Buy

Bewertungskennzahlen

The current forward P/E ratio for AquaBounty Technologies Inc (AQB) is 0.00, compared to its 5-year average forward P/E of -2.33.

Forward P/E

Fair
5Y Average P/E
-2.33
Current P/E
0.00
Überbewertet
1.11
Unterbewertet
-5.77

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
0.73
Current EV/EBITDA
0.00
Überbewertet
3.43
Unterbewertet
-1.96

Forward P/S

Fair
5Y Average P/S
12.09
Current P/S
5.19
Überbewertet
26.23
Unterbewertet
-2.06

Alphio AI Price Scenarios for AQB

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AQB

$0.69

Szenariopreis

B

Base

Base · 50%AQB

$0.57

Szenariopreis

B

Bear

Bear · 25%AQB

$0.44

Szenariopreis

AQB FAQ — answered by Alphio AI

AquaBounty Technologies, Inc. is a land-based aquaculture company. The Company’s technology advances in fish breeding, genetics, and health and nutrition. It locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system. It operates in the Consumer Non-Cyclicals sector.

AquaBounty Technologies Inc is not a good buy right now due to its current price of 1.25, which is significantly below its 200-day simple moving average of 0.985, indicating a bearish trend. Additionally, the RSI is at 37.249, suggesting the stock is nearing oversold territory but has not yet shown signs of recovery. The company has reported consistent losses, with a net income loss of -16,309,967 in Q2 2026, and a forward P/E ratio of 0, indicating no earnings growth expected in the near term. The main risk is the significant drop in stock price over the last 5 days by -4.58%, which reflects negative market sentiment and volatility.

1 analysts cover AQB: 1 rate it Buy, 0 Hold and 0 Sell.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten